University Of Colorado Anschutz Medical Campus Trial Shows Bionic Pancreas Improves Type 1 Diabetes Management Compared To Standard Insulin Delivery Methods
September 29, 2022
September 29, 2022
AURORA, Colorado, Sept. 29 (TNSjou) -- The University of Colorado Boulder Anschutz Medical campus issued the following news release:
* * *
This nationwide clinical trial funded through the National Institutes of Health includes participation from the Barbara Davis Center for Diabetes
* * *
A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose . . .
* * *
This nationwide clinical trial funded through the National Institutes of Health includes participation from the Barbara Davis Center for Diabetes
* * *
A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose . . .